69 related articles for article (PubMed ID: 2853998)
1. Cervical carcinoma: an experimental approach.
Cowan ME; Skinner GR
Cancer Surv; 1988; 7(3):469-79. PubMed ID: 2853998
[TBL] [Abstract][Full Text] [Related]
2. Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus.
Chen MH; Dong CY; Liu ZH; Skinner GR; Hartley CE
Vaccine; 1983 Dec; 1(1):13-6. PubMed ID: 6099637
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus subunit vaccine: characterization of the virus strain used and testing of the vaccine.
Hilfenhaus J; Moser H; Herrmann A; Mauler R
Dev Biol Stand; 1982; 52():321-31. PubMed ID: 6299841
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
6. [Herpes simplex virus vaccine studies: from past to present].
Us D
Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
[TBL] [Abstract][Full Text] [Related]
7. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
Gilman SC; Docherty JJ; Clarke A; Rawls WE
Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus. An expanding relationship to human cancer.
Smith JW
J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
[TBL] [Abstract][Full Text] [Related]
9. Subviral herpes simplex vaccine.
Kutinovà L; Slichtová V; Vonka V
Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
[TBL] [Abstract][Full Text] [Related]
11. Herpes-related polypeptides from a human cervical carcinoma cell line.
Suh M; Frost E
Cancer Detect Prev; 1986; 9(3-4):289-92. PubMed ID: 3017554
[TBL] [Abstract][Full Text] [Related]
12. The aetiological relationship between herpes simplex virus type 2 and carcinoma of the cervix: an unanswered or unanswerable question?
Maitland NJ
Cancer Surv; 1988; 7(3):457-67. PubMed ID: 2853997
[TBL] [Abstract][Full Text] [Related]
13. Cervical carcinogenesis with herpes simplex virus, type 2.
Wentz WB; Reagan JW; Heggie AD
Obstet Gynecol; 1975 Aug; 46(2):117-21. PubMed ID: 168521
[TBL] [Abstract][Full Text] [Related]
14. Roles of cytomegalovirus and Chlamydia trachomatis in the induction of cervical neoplasia in the mouse.
Heggie AD; Wentz WB; Reagan JW; Anthony DD
Cancer Res; 1986 Oct; 46(10):5211-4. PubMed ID: 3019522
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
16. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
17. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
18. Relation of cytohistopathology of genital herpesvirus infection to cervical anaplasia.
Naib ZM; Nahmias AJ; Josey WE; Zaki SA
Cancer Res; 1973 Jun; 33(6):1452-63. PubMed ID: 4352382
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
20. Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1213-21. PubMed ID: 9152241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
